[Journal logo]

Volume 67 
Part 2 
Page o428  
February 2011  

Received 1 January 2011
Accepted 11 January 2011
Online 15 January 2011

Key indicators
Single-crystal X-ray study
T = 293 K
Mean [sigma](C-C) = 0.004 Å
R = 0.048
wR = 0.134
Data-to-parameter ratio = 15.6
Details
Open access

Carboxymethyl ursolate monohydrate

aSchool of Pharmacy, China Pharmaceutical University, Tongjiaxiang No. 24 Nanjing, Nanjing 210009, People's Republic of China,bSchool of Chemistry and Chemical Engineering, Southeast University, Sipailou No. 2 Nanjing, Nanjing 210096, People's Republic of China, and cSchool of Pharmacy, Nanjing Medical University, Hanzhong Road No.140 Nanjing, Nanjing 210029, People's Republic of China
Correspondence e-mail: wjy090202@yahoo.com.cn

In the title compound, C28H50O5·H2O, all of the six-membered rings of the pentacyclic triterpene skeleton adopt chair conformations. In the crystal, molecules are linked by O-H...O and C-H...O hydrogen bonds.

Related literature

For the synthesis, see: Wen et al. (2006[Wen, X.-A., Zhang, P., Liu, J., Zhang, L.-Y., Wu, X.-M., Ni, P.-Z. & Sun, H.-B. (2006). Bioorg. Med. Chem. Lett. 16, 722-726.]). The crystal structure of ursolic acid is known from its ethanol solvate, see: Simon et al. (1992[Simon, A., Delage, C., Saux, M., Chulia, A. J., Najid, A. & Rigaud, M. (1992). Acta Cryst. C48, 726-728.]). For methyl uroslate-3-bromoacetate, see: Stout & Stevens (1963[Stout, G. H. & Stevens, K. L. (1963). J. Org. Chem. 28, 1259-1262.]). For methyl ursolate-3-p-bromobenzoate, see: Paton & Paul (1979[Paton, W. F. & Paul, I. C. (1979). Cryst. Struct. Commun. 8, 207-211.]). For background to ursolic acid derivatives and their biological activity, see: Es-saady et al. (1996[Es-saady, D., Simon, A., Ollier, M., Maurizis, J. C., Chulia, A. J. & Delage, C. (1996). Cancer Lett. 106, 193-197.]). For bond-length data, see: Allen et al. (1987[Allen, F. H., Kennard, O., Watson, D. G., Brammer, L., Orpen, A. G. & Taylor, R. (1987). J. Chem. Soc. Perkin Trans. 2, pp. S1-19.]).

[Scheme 1]

Experimental

Crystal data
  • C32H50O5·H2O

  • Mr = 532.74

  • Monoclinic, P 21

  • a = 13.338 (3) Å

  • b = 8.1010 (16) Å

  • c = 14.311 (3) Å

  • [beta] = 106.26 (3)°

  • V = 1484.5 (5) Å3

  • Z = 2

  • Mo K[alpha] radiation

  • [mu] = 0.08 mm-1

  • T = 293 K

  • 0.30 × 0.20 × 0.10 mm

Data collection
  • Enraf-Nonius CAD-4 diffractometer

  • Absorption correction: [psi] scan (North et al., 1968[North, A. C. T., Phillips, D. C. & Mathews, F. S. (1968). Acta Cryst. A24, 351-359.]) Tmin = 0.976, Tmax = 0.992

  • 5692 measured reflections

  • 5446 independent reflections

  • 4536 reflections with I > 2[sigma](I)

  • Rint = 0.025

  • 3 standard reflections every 200 reflections intensity decay: 1%

Refinement
  • R[F2 > 2[sigma](F2)] = 0.048

  • wR(F2) = 0.134

  • S = 1.00

  • 5446 reflections

  • 350 parameters

  • 1 restraint

  • H-atom parameters constrained

  • [Delta][rho]max = 0.18 e Å-3

  • [Delta][rho]min = -0.23 e Å-3

Table 1
Hydrogen-bond geometry (Å, °)

D-H...A D-H H...A D...A D-H...A
OW-HWB...O2i 0.85 2.41 2.839 (3) 112
OW-HWB...O4i 0.85 2.58 3.365 (3) 154
O1-H1A...O4ii 0.82 1.98 2.758 (3) 159
OW-HWA...O1iii 0.86 1.88 2.681 (3) 154
O5-H5B...OW 0.85 1.74 2.575 (3) 165
C12-H12A...OWi 0.93 2.57 3.455 (3) 159
Symmetry codes: (i) [-x, y-{\script{1\over 2}}, -z+1]; (ii) x+1, y-1, z; (iii) [-x+1, y+{\script{1\over 2}}, -z+1].

Data collection: CAD-4 EXPRESS (Enraf-Nonius, 1994)[Enraf-Nonius (1994). CAD-4 EXPRESS. Enraf-Nonius, Delft, The Netherlands.]; cell refinement: CAD-4 EXPRESS; data reduction: XCAD4 (Harms & Wocadlo, 1995[Harms, K. & Wocadlo, S. (1995). XCAD4. University of Marburg, Germany.]); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); molecular graphics: SHELXTL (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); software used to prepare material for publication: SHELXTL.


Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: HB5787 ).


Acknowledgements

The authors acknowledge support from the Natural Science Fundation of Jiangsu Province (No. BK2010538). The authors also thank Professor Hua-Qin Wang of the Analysis Centre, Nanjing University, for collecting the crystallographic data.

References

Allen, F. H., Kennard, O., Watson, D. G., Brammer, L., Orpen, A. G. & Taylor, R. (1987). J. Chem. Soc. Perkin Trans. 2, pp. S1-19.
Enraf-Nonius (1994). CAD-4 EXPRESS. Enraf-Nonius, Delft, The Netherlands.
Es-saady, D., Simon, A., Ollier, M., Maurizis, J. C., Chulia, A. J. & Delage, C. (1996). Cancer Lett. 106, 193-197.  [ChemPort] [PubMed] [ISI]
Harms, K. & Wocadlo, S. (1995). XCAD4. University of Marburg, Germany.
North, A. C. T., Phillips, D. C. & Mathews, F. S. (1968). Acta Cryst. A24, 351-359.  [CrossRef] [details]
Paton, W. F. & Paul, I. C. (1979). Cryst. Struct. Commun. 8, 207-211.  [ChemPort]
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.  [CrossRef] [details]
Simon, A., Delage, C., Saux, M., Chulia, A. J., Najid, A. & Rigaud, M. (1992). Acta Cryst. C48, 726-728.  [CrossRef] [details]
Stout, G. H. & Stevens, K. L. (1963). J. Org. Chem. 28, 1259-1262.  [CrossRef] [ChemPort]
Wen, X.-A., Zhang, P., Liu, J., Zhang, L.-Y., Wu, X.-M., Ni, P.-Z. & Sun, H.-B. (2006). Bioorg. Med. Chem. Lett. 16, 722-726.  [CrossRef] [PubMed] [ChemPort]


Acta Cryst (2011). E67, o428  [ doi:10.1107/S1600536811001619 ]

This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.